|
|
|
|
| LEADER |
01000naa a22002652 4500 |
| 001 |
NLM264662997 |
| 003 |
DE-627 |
| 005 |
20231224210606.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
231224s2018 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1016/j.clim.2016.09.010
|2 doi
|
| 028 |
5 |
2 |
|a pubmed24n0882.xml
|
| 035 |
|
|
|a (DE-627)NLM264662997
|
| 035 |
|
|
|a (NLM)27664933
|
| 035 |
|
|
|a (PII)S1521-6616(16)30400-4
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Huber, Amanda K
|e verfasserin
|4 aut
|
| 245 |
1 |
3 |
|a An emerging role for eotaxins in neurodegenerative disease
|
| 264 |
|
1 |
|c 2018
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 01.07.2019
|
| 500 |
|
|
|a Date Revised 08.04.2022
|
| 500 |
|
|
|a published: Print-Electronic
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a Copyright © 2016 Elsevier Inc. All rights reserved.
|
| 520 |
|
|
|a Eotaxins are C-C motif chemokines first identified as potent eosinophil chemoattractants. They facilitate eosinophil recruitment to sites of inflammation in response to parasitic infections as well as allergic and autoimmune diseases such as asthma, atopic dermatitis, and inflammatory bowel disease. The eotaxin family currently includes three members: eotaxin-1 (CCL11), eotaxin-2 (CCL24), and eotaxin-3 (CCL26). Despite having only ~30% sequence homology to one another, each was identified based on its ability to bind the chemokine receptor, CCR3. Beyond their role in innate immunity, recent studies have shown that CCL11 and related molecules may directly contribute to degenerative processes in the central nervous system (CNS). CCL11 levels increase in the plasma and cerebrospinal fluid of both mice and humans as part of normal aging. In mice, these increases are associated with declining neurogenesis and impaired cognition and memory. In humans, elevated plasma levels of CCL11 have been observed in Alzheimer's disease, amyotrophic lateral sclerosis, Huntington's disease, and secondary progressive multiple sclerosis when compared to age-matched, healthy controls. Since CCL11 is capable of crossing the blood-brain barrier of normal mice, it is plausible that eotaxins generated in the periphery may exert physiological and pathological actions in the CNS. Here, we briefly review known functions of eotaxin family members during innate immunity, and then focus on whether and how these molecules might participate in the progression of neurodegenerative diseases
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a Review
|
| 650 |
|
4 |
|a Aging
|
| 650 |
|
4 |
|a CCL11
|
| 650 |
|
4 |
|a Eotaxin
|
| 650 |
|
4 |
|a Multiple sclerosis
|
| 650 |
|
4 |
|a Neurodegeneration
|
| 650 |
|
4 |
|a Neurogenesis
|
| 650 |
|
7 |
|a Chemokine CCL11
|2 NLM
|
| 650 |
|
7 |
|a Chemokine CCL24
|2 NLM
|
| 650 |
|
7 |
|a Chemokine CCL26
|2 NLM
|
| 650 |
|
7 |
|a Receptors, CCR3
|2 NLM
|
| 700 |
1 |
|
|a Giles, David A
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Segal, Benjamin M
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Irani, David N
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 189(2018) vom: 28. Apr., Seite 29-33
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnns
|
| 773 |
1 |
8 |
|g volume:189
|g year:2018
|g day:28
|g month:04
|g pages:29-33
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.clim.2016.09.010
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_11
|
| 912 |
|
|
|a GBV_ILN_24
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 189
|j 2018
|b 28
|c 04
|h 29-33
|